Abbott denies report of $25B bid for St. Jude Medical

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

Abbott Laboratories denied a  Financial Times report that it was prepared to bid $25 billion to acquire St. Jude Medical. St. Jude, which is based in Minnesota,  declined to comment when contacted by the  Minneapolis Star Tribune.

Since 2008, the companies have had an  alliance in which they jointly sell U.S. hospitals a portfolio of products in interventional cardiology, cardiac rhythm management, electrophysiology and intravascular imaging and diagnostic technologies.

In July, St. Jude Medical  agreed to acquire Thoratec for approximately $3.4 billion to expand its heart failure business.